Cardio-Metabolic Health Venezuelan Study (EVESCAM): Design and Implementation

Published: Invest Clin
Date:
Authors: Ramfis Nieto-Martínez, María Inés Marulanda, Juan P González-Rivas, Eunice Ugel, Maritza Durán, Noel Barengo, Pablo Aschner, Mario Patiño, Luis López Gómez, Pedro Monsalve, Héctor Marcano, Hermes Florez
Abstract:
LINK TO RESEARCH https://pubmed.ncbi.nlm.nih.gov/29939500/ ABSTRACT The EVESCAM (EstudioVenezolano de Salud Cardio-Metabólica) is the first national, population survey in Venezuela, designed to examine the prevalence of diabetes and cardio-metabolic risk factors...

Transcultural Endocrinology: Adapting Type-2 Diabetes Guidelines on a Global Scale

Published: Endocrinology and Metabolism Clinics
Date:
Authors: Ramfis Nieto-Martínez 1 , Juan P González-Rivas 2 , Hermes Florez 3 , Jeffrey I Mechanick 4
Abstract:
Type-2 diabetes (T2D) needs to be prevented and treated effectively to reduce its burden and consequences. White papers, such as evidence-based clinical practice guidelines (CPG) and their more portable versions, clinical practice algorithms and clinical checklists, may improve clinical decision-making and diabetes outcomes

Diabetes Care in Venezuela

Published: Annals of Global Health
Date:
Authors: Ramfis Nieto-Martínez 1 , Juan P González-Rivas 2 , Marcos Lima-Martínez 3 , Victoria Stepenka 4 , Alejandro Rísquez 5 , Jeffrey I Mechanick 6
Abstract:
The incidence of type 2 diabetes (T2D) and its economic burden have increased in Venezuela, posing difficult challenges in a country already in great turmoil.

Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331,288 participants

Published: The Lancet Diabetes & Endocrinology
Date:
Authors: NCD Risk Factor Collaboration (NCD-RisC)
Abstract:
Diabetes has been defined on the basis of different biomarkers, including fasting plasma glucose (FPG), 2-h plasma glucose in an oral glucose tolerance test (2hOGTT), and HbA1c. We assessed the effect of different diagnostic definitions on both the population prevalence of diabetes and the classification of previously undiagnosed individuals as having diabetes versus not having diabetes in a pooled analysis of data from population-based health examination surveys in different regions.

Transcultural diabetes nutrition algorithm (tDNA): Venezuelan application

Published: Nutrients
Date:
Authors: Ramfis Nieto-Martínez 1 , Osama Hamdy 2 , Daniel Marante 3 , María Inés Marulanda 4 , Albert Marchetti 5 , Refaat A Hegazi 6 , Jeffrey I Mechanick 7
Abstract:
Medical nutrition therapy (MNT) is a necessary component of comprehensive type 2 diabetes (T2D) management, but optimal outcomes require culturally-sensitive implementation.

Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial

Published: The Lancet
Date:
Authors: Richard M Bergenstal 1, Carol Wysham, Leigh Macconell, Jaret Malloy, Brandon Walsh, Ping Yan, Ken Wilhelm, Jim Malone, Lisa E Porter, DURATION-2 Study Group
Abstract:
Most patients with type 2 diabetes begin pharmacotherapy with metformin, but eventually need additional treatment. We assessed the safety and efficacy of once weekly exenatide, a glucagon-like peptide 1 receptor agonist, versus maximum approved doses of the dipeptidyl peptidase-4 inhibitor, sitagliptin, or the thiazolidinedione, pioglitazone, in patients treated with metformin.

The prevalence of impaired glucose metabolism in Hispanics with two or more risk factors for metabolic syndrome in the primary care setting

Published: Journal of the American Academy of Nurse Practitioners
Date:
Authors: Claudia P Neira 1 , Margaret Hartig, Patricia A Cowan, Pedro A Velasquez-Mieyer
Abstract:
LINK TO RESEARCH https://pubmed.ncbi.nlm.nih.gov/19302694/ ABSTRACT Purpose: The purposes of this observational prospective study were (a) to identify the prevalence of undiagnosed impaired glucose metabolism (IGM) including impaired fasting glucose (IFG),...